Skip to main content
Braster S.A. logo

Braster S.A. — Investor Relations & Filings

Ticker · BRA ISIN · PLBRSTR00014 LEI · 259400GV3T3LOS094487 WAR Manufacturing
Filings indexed 1,512 across all filing types
Latest filing 2025-11-26 M&A Activity
Country PL Poland
Listing WAR BRA

About Braster S.A.

https://www.braster.eu/en

Braster S.A. is a medical technology company specializing in the development, production, and marketing of diagnostic devices for breast health. Its core product is the Braster System, a medical device designed for regular, in-home breast examination. The system utilizes a proprietary contact thermography method with liquid crystal technology to monitor temperature distribution within the breasts. It functions by detecting and recording areas of elevated temperature, which may indicate pathological changes. The Braster device is intended as a non-invasive, complementary screening tool to be used by women as an adjunct to standard diagnostic procedures such as mammography and ultrasound, promoting systematic breast health monitoring.

Recent filings

Filing Released Lang Actions
List intencyjny od głównego przedstawiciela Specjalnej Komisji ds. Agentów Zdrowia i Kontroli Chorób Endemicznych Parlamentu Brazylii - Content (PL)
M&A Activity Classification · 100% confidence The document is an announcement from Braster S.A. regarding the receipt of a letter of intent from a Brazilian health commission concerning the potential acquisition of their technology. It details the nature of the partnership, the scope of the project, and the estimated financial impact. Since this is a corporate announcement regarding a specific business development/partnership opportunity rather than a financial report, a dividend notice, or a management change, it falls under the general regulatory announcement category.
2025-11-26 Polish
List intencyjny od wiceprzewodniczącego Komisji Zdrowia Parlamentu Brazylii - Content (PL)
Regulatory Filings Classification · 100% confidence The document is an announcement from Braster S.A. regarding the receipt of a letter of intent from the Brazilian Health Commission. It details potential business opportunities, market expansion, and estimated revenue projections. Since this is a corporate announcement regarding a business development/partnership opportunity that does not fit into specific categories like M&A (which usually implies a merger or acquisition of the company itself) or financial reporting, it falls under the general regulatory announcement category.
2025-11-20 Polish
Lista akcjonariuszy posiadających co najmniej 5% głosów na Zwyczajnym Walnym Zgromadzeniu w dniu 14 listopada 2025 r. - Content (PL)
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document identifies specific shareholders who held at least 5% of the voting rights at the company's Annual General Meeting. This is a standard disclosure requirement for major shareholding notifications following a general meeting, which falls under the category of Major Shareholding Notification.
2025-11-14 Polish
Formularz
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Proxy Voting Form' (Formularz do wykonywania prawa głosu przez pełnomocnika) for an upcoming Annual General Meeting (Zwyczajne Walne Zgromadzenie) of Bras S.A. It contains the agenda, proposed resolutions, and instructions for shareholders to authorize a proxy to vote on their behalf. This type of document is classified as a Proxy Solicitation & Information Statement, as it provides the necessary materials for shareholders to exercise their voting rights at a meeting.
2025-10-17 Polish
Liczba akcji
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document provides information regarding the total number of shares and voting rights in connection with an upcoming General Meeting. This type of disclosure is a standard regulatory requirement for companies prior to a shareholder meeting to inform investors of their voting power. It does not constitute a proxy solicitation, a report publication, or a voting result, but rather a regulatory disclosure of share capital structure. Therefore, it falls under the general regulatory filing category.
2025-10-17 Polish
Pełnomocnictwo
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a proxy form (Pełnomocnictwo) for shareholders to appoint a representative to vote at the Annual General Meeting (Zwyczajne Walne Zgromadzenie) of Bras SA. This type of document is a standard material provided to shareholders to facilitate their participation and voting in corporate meetings, which falls under the category of Proxy Solicitation & Information Statement.
2025-10-17 Polish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.